Kringle Pharma, Inc. (TYO:4884)

Kringle Pharma Balance Sheet

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	1,886	2,313	2,136	2,756	2,137	2,102
Cash & Short-Term Investments	1,886	2,313	2,136	2,756	2,137	2,102
Cash Growth	-24.23%	8.29%	-22.50%	28.97%	1.67%	1166.26%
Accounts Receivable	-	-	7	-	6	105
Other Receivables	33	57	74	67	76	23
Receivables	33	57	81	67	82	128
Inventory	250	294	364	349	315	46
Prepaid Expenses	-	23	14	11	12	4
Other Current Assets	96	68	22	24	88	69
Total Current Assets	2,265	2,755	2,617	3,207	2,634	2,349
Long-Term Investments	24	1	1	1	1	1
Other Long-Term Assets	1	1	-	-	-	-
Total Assets	2,290	2,757	2,618	3,208	2,635	2,350
Accounts Payable	-	1	-	1	-	-
Accrued Expenses	-	21	5	2	3	2
Current Income Taxes Payable	109	37	173	54	32	74
Other Current Liabilities	46	69	31	105	92	83
Total Current Liabilities	155	128	209	162	127	159
Other Long-Term Liabilities	527	522	388	258	2	3
Total Liabilities	682	650	597	420	129	162
Common Stock	12	11	97	59	51	300
Additional Paid-In Capital	2,841	2,835	3,095	3,057	2,755	2,654
Retained Earnings	-1,268	-756	-1,185	-331	-301	-765
Comprehensive Income & Other	23	17	14	3	1	-1
Shareholders' Equity	1,608	2,107	2,021	2,788	2,506	2,188
Total Liabilities & Equity	2,290	2,757	2,618	3,208	2,635	2,350
Net Cash (Debt)	1,886	2,313	2,136	2,756	2,137	2,102
Net Cash Growth	-24.23%	8.29%	-22.50%	28.97%	1.67%	1166.26%
Net Cash Per Share	278.68	361.45	396.27	567.55	514.49	38068.68
Filing Date Shares Outstanding	6.84	6.81	5.41	5.38	4.33	1.29
Total Common Shares Outstanding	6.84	6.81	5.41	5.38	4.33	1.29
Working Capital	2,110	2,627	2,408	3,045	2,507	2,190
Book Value Per Share	235.19	309.37	373.88	518.16	578.13	1690.75
Tangible Book Value	1,608	2,107	2,021	2,788	2,506	2,188
Tangible Book Value Per Share	235.19	309.37	373.88	518.16	578.13	1690.75

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.